CK2 INTRONLESS GENE AMPLIFICATION IN NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Hung, Ming-Szu [1 ]
Lin, Yu-Ching [1 ]
Xu, Zhidong [2 ]
Jablons, David M. [2 ]
You, Liang [2 ]
机构：
[1] Chang Gung Mem Hosp, Keelung City, Taiwan
[2] Univ Calif, Oakland, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
amplification; NSCLC; oncogene; CK2;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S453 / S454
页数：2
相关论文
共 50 条
  • [41] Gemcitabine in non-small cell lung cancer (NSCLC)
    Manegold, C
    Zatloukal, P
    Krejcy, K
    Blatter, J
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 29 - 42
  • [42] Pemetrexed in advanced non-small cell lung cancer
    Gridelli, Cesare
    Maione, Paolo
    Rossi, Antonio
    Bareschino, Maria Anna
    Schettino, Clorinda
    Sacco, Paola Claudia
    Zeppa, Rosario
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (02) : 311 - 317
  • [43] Durvalumab for the treatment of non-small cell lung cancer
    Murakami, Shuji
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (12) : 1009 - 1016
  • [44] Durvalumab for the treatment of non-small cell lung cancer
    Mezquita, Laura
    Planchard, David
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2018, 12 (08) : 627 - 639
  • [45] Afatinib for the treatment of non-small cell lung cancer
    Biello, Federica
    Maggioni, Claudia
    Rijavec, Erika
    Genova, Carlo
    Barletta, Giulia
    Gualco, Elisa
    Truini, Anna
    Coco, Simona
    Dal Bello, Maria Giovanna
    Vanni, Irene
    Alama, Angela
    Boccardo, Francesco
    Grossi, Francesco
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (11): : 1357 - 1364
  • [46] Cellular Senescence in Non-Small Cell Lung Cancer
    Zhu, Huangkai
    Sun, Jiaen
    Zhang, Chong
    Li, Pei
    Tan, Chuntao
    Yang, Minglei
    Zhao, Guofang
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (12):
  • [47] Targeted therapies for non-small cell lung cancer
    Papaetis, G. S.
    Roussos, C.
    Syrigos, K. N.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (27) : 2810 - 2831
  • [48] Proton Therapy in Non-small Cell Lung Cancer
    Shane Mesko
    Daniel Gomez
    Current Treatment Options in Oncology, 2018, 19
  • [49] Aptamers in Non-Small Cell Lung Cancer Treatment
    Wieleba, Irena
    Wojas-Krawczyk, Kamila
    Krawczyk, Pawel
    MOLECULES, 2020, 25 (14):
  • [50] BRAF Inhibitors in Non-Small Cell Lung Cancer
    Sforza, Vincenzo
    Palumbo, Giuliano
    Cascetta, Priscilla
    Carillio, Guido
    Manzo, Anna
    Montanino, Agnese
    Sandomenico, Claudia
    Costanzo, Raffaele
    Esposito, Giovanna
    Laudato, Francesca
    Damiano, Simona
    Forte, Cira Antonietta
    Frosini, Giulia
    Farese, Stefano
    Piccirillo, Maria Carmela
    Pascarella, Giacomo
    Normanno, Nicola
    Morabito, Alessandro
    CANCERS, 2022, 14 (19)
12345